The role of nuclear medicine in the diagnosis of common and specific diabetic infections

Hellenic Journal of Nuclear Medicine

Volumn 13, Issue 2, 2010, Pages 150-158

  Papanas, Nikolaos ^a   Zissimopoulos, Athanassios ^b   Maltezos, Efstratios ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Diabetes mellitus; Diabetic foot; Infections; Nuclear medicine; Scintigraphy

Indexed keywords

DIGLYCINE TECHNETIUM TC 99M; FLUORODEOXYGLUCOSE F 18; GALLIUM 67; GALLIUM CITRATE GA 67; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; HUMAN IMMUNOGLOBULIN TECHNETIUM TC 99M; INDIUM 111; MEDRONATE TECHNETIUM TC 99M; MERTIATIDE TC 99M; PENTETATE TECHNETIUM TC 99M; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; SUCCIMER TC 99M; TECHNETIUM 99M; TECHNETIUM SULFUR COLLOID TC 99M; TRACER; UNCLASSIFIED DRUG;

BACTEREMIA; BONE SCINTISCANNING; COMPUTER ASSISTED TOMOGRAPHY; CYSTITIS; DIABETES MELLITUS; DIABETIC FOOT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EMPHYSEMATOUS CHOLECYSTITIS; EXTERNAL OTITIS; FOLLOW UP; HUMAN; INFECTION; LUNG TUBERCULOSIS; MUCORMYCOSIS; MYCOSIS; NEUROPATHIC JOINT DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MEDICINE; OSTEOMYELITIS; PERIRENAL ABSCESS; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PYELONEPHRITIS; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; URINARY TRACT INFECTION;

DIABETES COMPLICATIONS; FOOT DISEASES; HUMANS; INFECTION; NUCLEAR MEDICINE;

EID: 77956359916     PISSN: 11081430     EISSN: 17905427     Source Type: Journal    
DOI: None     Document Type: Review

References (121)

1. Wild S, Roglic G, Green A et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53.
2. Coliaguri S, Borch-Johnsen K, Glümer C et al. There really is an epidemic of type 2 diabetes. Diabetologia 2005; 48: 1459-63. (Pubitemid 41175496)
3. Rayfield EJ, Ault MJ, Keusch GT et al. Infection and diabetes: the case for glucose control. Am J Med 1982; 72: 439-50.
4. Moutschen MP, Scheen AJ, Lefevre PJ. Impaired immune response in diabetes mellitus. Analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabetes Metab 1992; 18: 187-201.
5. Moutschen M. Alterations in natural immunity and risk of infection in patients with diabetes mellitus. Rev Med Liege 2005; 60: 541-4.
6. Peleg AY, Weerarathna T, McCarthy JS, Davis TM. Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev 2007; 23: 3-13.
7. Rubinstein R, Genaro AM, Motta A et al. Impaired immune responses in streptozotocin-induced type I diabetes in mice. Involvement of high glucose. Clin Exp Immunol 2008; 154: 235-46.
8. Mowat AG, Baum J. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl J Med 1971; 284: 621-7.
9. Nolan CM, Beaty HN, Bagdate JD. Further characterization of the impaired bacteriocidical function of granulocytes in patients with poorly controlled diabetes. Diabetes 1978; 27: 889-94.
10. Diepersloot RJ, Bouter KP, Beyer WE et al. Humoral immune response and delayed type hypersensitivity to influenza vaccine in patients with diabetes mellitus. Diabetologia 1987; 30: 397-401.
11. Liu BF, Miyata S, Kojima H et al. Low phagocytic activity of resident peritoneal macrophages in diabetic mice: relevance to the formation of advanced glycation end products. Diabetes 1999; 48: 2074-82.
12. Shah BR, Hux JE. Quantifying the risk of infections for people with diabetes. Diabetes Care 2003: 26: 510-3.
13. Lipsky BA, Berendt AR, Deery HG et al. Diagnosis and treatment of diabetic foot infections. Plast Reconstr Surg 2006; 117(7 Suppl): 212S-238S.
14. Dang CN, Prasad YD, Boulton AJ, Jude EB. Methicillin-resistant Staphylococcus aureus: a worsening problem. Diabet Med 2003; 20: 159-61.
15. Frykberg RG, Zgonis T, Armstrong DG et al. Diabetic foot disorders: A clinical practice guideline (2006 revision). J Foot Ankle Surg 2006; 45: 5 Suppl 1: S1-S66.
16. Mackowiak PA, Martin RM, Jones SR, Smith JW. Pharyngeal colinization by Gram-negative bacilli in aspiration-prone persons. Arch Int Med 1978; 138: 1224-7.
17. Fine MJ, Smith MA, Carson CA et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 1996; 275: 134-41.
18. Winterbauer RH, Bedon GA, Ball WA. Recurrent pneumonia. Predisposing illness and clinical patterns in 158 patients. Ann Intern Med 1969; 70: 689-92.
19. Patterson JE, Andriole VT. Bacterial urinary tract infections in diabetes mellitus. Infect Dis Clin North Am 1997; 11: 735-50.
20. Gupta KL, Sakhuja V, Khandelwal N et al. Renal papillary necrosis in diabetes mellitus. J Assoc Physicians India 1990; 38: 908-11.
21. Groop L, Laasonen L, Edgren J Renal papillary necrosis in patients with IDDM. Diabetes Care 1989; 12: 198-202.
22. Butterly DW, Schwab SJ. Dialysis access infections. Curr Opin Nephrol Hypertens 2000; 9: 631-5.
23. Nassar GM, Ayus JC. Infectious complications of the hemodialysis access. Kidney Int 2001; 60: 1-13.
24. Dryden MS. Skin and soft tissue infection: microbiology and epidemiology. Int J Antimicrob Agents 2009; 34 Suppl 1: S2-7.
25. Bristow IR, Spruce MC. Fungal foot infection, cellulitis and diabetes: a review. Diabet Med 2009; 26: 548-51.
26. Aragón-Sánchez J, Quintana-Marrero Y, Lázaro- Martínez JL et al. Necrotizing soft-tissue infections in the feet of patients with diabetes: outcome of surgical treatment and factors associated with limb loss and mortality. Int J Low Extrem Wounds 2009; 8: 141-6.
27. Czymek R, Hildebrand P, Kleemann M et al. New insights into the epidemiology and etiology of Fournier's gangrene: a review of 33 patients. Infection 2009; 37: 306-12.
28. Kara E, Müezzinoǧlu T, Temeltas G et al. Evaluation of risk factors and severity of a life threatening surgical emergency: Fournier's gangrene (a report of 15 cases). Acta Chir Belg 2009; 109: 191-7.
29. Papanas N, Maltezos E. The diabetic hand: a forgotten complication? J Diabetes Complications 2010; 24: 154-62.
30. Ahmed ME, Mahmoud SM, Mahadi SI et al. Hand sepsis in patients with diabetes mellitus. Saudi Med J 2009; 30: 1454-8.
31. Baldwin N, Scott AR, Heller SR et al. Vertebral and paravertebral sepsis in diabetes: an easily missed cause of backache. Diabet Med 1985; 2: 395-7. (Pubitemid 16202661)
32. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care 1990; 13: 513-21.
33. Edmonds ME, Foster AVM, Sanders LJ. Stage 4: the infected foot. In: A Practical Manual of Diabetic Footcare, Edmonds ME, Foster AVM, Sanders LJ (Editors), Blackwell, Oxford, 2004, 102-40.
34. Prompers L, Huijberts M, Apelqvist J et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologie 2007; 50: 18-25.
35. Papanas N, Maltezos E. The diabetic foot: established and emerging treatments. Acta Clin Belg 2007; 62: 230-8.
36. Tentolouris N, Petrikkos G, Vallainou N et al. Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers. Clin Microbiol Infect 2006; 12: 186-9.
37. Boulton AJM. The diabetic foot: from art to science. The 18th Camillo Golgi lecture. Diabetologia 2004; 47: 1343-53.
38. Papanas N, Maltezos E, Edmonds M. St. Vincent declaration after 15 years or who cleft the devil's foot? Vasa 2006; 35: 3-4.
39. Papanas N, Maltezos E, Edmonds M. The diabetic foot: a plea for the elementary? Acta Diabetol 2006; 43: 152-3.
40. Watkins PJ. The diabetic foot. BMJ 2003; 326: 977-9.
41. Schaper NC. Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies. Diabetes Metab Res Rev 2004: 20: suppl 1: S90-S95.
42. Kemper J, Kuijper EJ, Mirck PG, Balm AJ. Recovery from rhinocerebral mucormycosis in a ketoacidotic diabetic patient: a case report. J Laryngol Otol 1993; 107: 233-5. (Pubitemid 23151735)
43. Ganesh R, Manikumar S, Vasanthi T. Rhinocerebral mucormycosis in an adolescent with type 1 diabetes mellitus: case report. Ann Trop Paediatr 2008; 28: 297-300.
44. Giamarellou H. Malignant otitis externa: the therapeutic evolution of a letal infection. J Antimicrob Hemother 1992; 30: 745-51.
45. Carfrae MJ, Kesser BW. Malignant otitis externa. Otolaryngol Clin North Am 2008; 41: 537-49.
46. Thio D, Reece P, Herdman R. Necrotizing otitis externa: a painless reminder. Eur Arch Otorhinolaryngol 2008; 265: 907-10.
47. Pappas S, Peppas ThA, Sotiropoulos A, Katsadoros D. Emphysematous pyelonephritis: a case report and review of the literature. Diabet Med 1993; 10: 574-6. (Pubitemid 23189766)
48. Huang JJ, Tseng CC. Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis. Arch Intern Med 2000; 160: 797-805.
49. Dutta P, Bhansali A, Singh SK et al. Presentation and outcome of emphysematous renal tract disease in patients with diabetes mellitus. Urol Int 2007; 78: 13-22.
50. Shu T, Green JM, Orihuela E. Renal and perirenal abscesses in patients with otherwise anatomically normal urinary tracts. J Urol 2004; 172: 148-50.
51. Bhansali A, Sridhar C, Choudhary S. Type 2 diabetes, emphysematous pyelonephritis and emphsematous cholecystitis. J Assoc Physicians India 2004; 52: 124. (Pubitemid 44194612)
52. Bhansali A, Bhadada S, Shridhar C et al. Concurrent emphysematous pyelonephritis and emphysematous cholecystitis in type 2 diabetes. Australas Radiol 2004; 48: 411-3. (Pubitemid 39421092)
53. Elsayes KM, Menias CO, Sierra L et al. Gastrointestinal manifestations of diabetes mellitus: spectrum of imaging findings. J Comput Assist Tomogr 2009; 33: 86-9.
54. Frykberg RG, Zgonis T, Armstrong DG et al. Diabetic foot disorders: A clinical practice guideline (2006 revision). J Foot Ankle Surg 2006; 45: 5 Suppl 1: S1-S66.
55. Berendt AR, Peters EJ, Bakker K et al. Specific guidelines for treatment of diabetic foot osteomyelitis. Diabetes Metab Res Rev 2008; 24 Suppl 1: S190-191.
56. Byren I, Peters EJ, Hoey C et al. Pharmacotherapy of diabetic foot osteomyelitis. Expert Opin Pharmacother 2009; 10: 3033-47.
57. Lipsky BA. Bone of contention: diagnosing diabetic foot osteomyelitis. Clin Infect Dis 2008; 47: 528-30.
58. Donovan A, Schweitzer ME. Current concepts in imaging diabetic pedal osteomyelitis. Radiol Clin North Am 2008; 46: 1105-24.
59. Sella EJ. Current concepts review: diagnostic imaging of the diabetic foot. Foot Ankle Int 2009; 30: 568-76.
60. Liu PT, Dorsey ML. MRI of the foot for suspected osteomyelitis: improving radiology reports for orthopaedic surgeons. Semin Musculoskelet Radiol 2007; 11: 28-35.
61. Palestro CJ, Love C. Nuclear medicine and diabetic foot infections. Semin Nucl Med 2009; 39: 52-65.
62. Basu S, Chryssikos T, Moghadam-Kia S et al. Positron emission tomography as a diagnostic tool in infection: present role and future possibilities. Semin Nucl Med 2009; 39: 36-51.
63. Keenan AM, Tindel NL, Alavi A. Diagnosis of pedal osteomyelitis in diabetic patients using current scintigraphic techniques. Arch Intern Med 1989; 149: 2262-6.
64. Rajbhandari SM, Jenkins RC, Davies C, Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologie 2002; 45: 1085-96.
65. Berendt AR, Lipsky BA. Challenges in the infected diabetic foot: osteomyelitis and Methicillin-resistant Staphylococcus aureus. In: Boulton AJM, Cavanagh PR, Rayman G Eds, The foot in diabetes, 4th Edit, Chichester: John Wiley, 2006, 169-85.
66. Maurer A, Millmond SH, Knight LC et al. Infection in diabetic osteoarthropathy: Use of indium-labeled leukocytes for diagnosis. Radiology 1986; 151: 221-5. (Pubitemid 16031459)
67. Park HM, Wheat LJ, Siddiqui AR et al. Scintigraphic evaluation of diabetic osteomyelitis: concise communication. J Nucl Med 1982; 23: 569-73.
68. 111In-leukocyte scintigraphy. Am J Roentgenol 1991; 157: 527-31.
69. Johnson JE, Kennedy EJ, Shereff MJ et al. Prospective study of bone, indium-111-labeled white blood cell, and gallium-67 scanning for the evaluation of osteomyelitis in the diabetic foot. Foot Ankle Int 1996; 17: 10-16.
70. Harvey J, Cohen MM. Technetium-99-labeled leukocytes in diagnosing diabetic osteomyelitis in the foot. J Foot Ankle Surg 1997; 36: 209-14.
71. 99mTc-HMPAO labeled leukocytes. J Foot Ankle Surg 1997; 36: 120-6.
72. Devillers A, Moisan A, Hennion F et al. Contribution of technetium-99m hexamethylpropylene amine oxime labelled leucocyte scintigraphy to the diagnosis of diabetic foot infection. Eur J Nucl Med 1998; 25: 132-8.
73. Palestro CJ, Caprioli R, Love C et al. Rapid diagnosis of pedal osteomyelitis in diabetics with a technetium-99m-labeled monoclonal antigranulocyte antibody. J Foot Ankle Surg 2003; 42: 2-8.
74. Gnanasegaran G, Chicklore S, Vijayanathan S et al. Diabetes and bone: advantages and limitations of radiological, radionuclide and hybrid techniques in the assessment of diabetic foot. Minerva Endocrinol 2009; 34: 237-54.
75. Alazraki N, Dries D, Datz F et al. Value of a 24-hour image (four-phase bone scan) in assessing osteomyelitis in patients with peripheral vascular disease. J Nucl Med 1985; 26: 711-7. (Pubitemid 16005491)
76. Israel O, Gips S, Jerushalmi J et al. Osteomyelitis and soft-tissue infection: differential diagnosis with 24 hour/4 hour ratio of Tc-99m MDP uptake. Radiology 1987; 163: 725-6.
77. Tomas MB, Patel M, Marwin SE, Palestro CJ. The diabetic foot. Br J Radiol 2000; 73: 443-50.
78. Seldin DW, Heiken JP, Feldman F, Alderson PO. Effect of soft-tissue pathology on detection of pedal osteomyelitis in diabetics. J Nucl Med 1985; 26: 988-93.
79. 67Ga imaging following insertion of orthopedic devices. Radiology 1979; 133: 717-21. (Pubitemid 10215275)
80. 67Ga imaging in osteomyelitis, cellulitis and septic arthritis. Radiology 1977; 123: 123-9.
81. 99mTc-MDP bone scintigraphy, and radiography. Radiology 1985; 155: 501-6.
82. Newman LG, Waller J, Palestro CJ et al. Unsuspected osteomyelitis in diabetic foot ulcers. Diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinoline. JAMA 1991; 266: 1246-51.
83. 111In is superior to magnetic resonance imaging in diagnosis of clinically unsuspected osteomyelitis in diabetic foot ulcers. Diabetes Care 1992; 15: 1527-30.
84. 99mTc-MDP bone scintigraphy. Diabetes Metab 2002; 28: 485-90. (Pubitemid 36077151)
85. 99mTc- labelled antileukocyte fragment Fab′ and Tc-99m-HMPAO leukocyte scintigraphy in the diagnosis of bone and joint infections: a prospective study. Nucl Med Commun 2000; 21: 747-53.
86. Rubello D, Casara D, Maran A et al. Role of anti-granulocyte Fab′ fragment antibody scintigraphy (LeukoScan) in evaluating bone infection: acquisition protocol, interpretation criteria and clinical results. Nucl Med Commun 2004; 25: 39-47.
87. 99mTc-nanocolloid scintigraphy for assessing osteomyelitis in diabetic neuropathic feet. Clin Radiol 1998; 53: 120-5.
88. Palestro CJ, Mehta HH, Patel M et al. Marrow versus infection in the Charcot joint: indium-111 leukocyte and technetium-99m sulfur colloid scintigraphy. J Nucl Med 1998; 39: 346-50. (Pubitemid 28114530)
89. Nawaz A, Torigian DA, Siegelman ES et al. Diagnostic Performance of FDG-PET, MRI, and Plain Film Radiography (PFR) for the Diagnosis of Osteomyelitis in the Diabetic Foot. Mol Imaging Biol 2010; 12: 335-42.
90. 99mTc-HMPAO-labeled leukocyte imaging. J Nucl Med 2009; 50: 1042-6.
91. Parisier SC, Lucente FE, Som PM et al. Nuclear scanning in necrotizing progressive "malignant" external otitis. Laryngoscope 1982; 92: 1016-9.
92. Sostre S, Rivera JV. Bone scanning in malignant external otitis. Bol Asoc Med P R 1986; 78: 197-8.
93. Strashun AM, Nejatheim M, Goldsmith SJ. Malignant external otitis: early scintigraphic detection. Radiology 1984; 150: 541-5.
94. Malamitsi J, Maragoudakis P, Papafragou K et al. Preliminary results on scintigraphic evaluation of malignant external otitis. Eur J Nucl Med 1993; 20: 511-4.
95. Ohta H, Yonamine Y, Narabayashi I. What is the diagnosis? Malignant external otitis (MEO) (Pseudomonas osteomyelitis of the temporal bone). Ann Nucl Med 2003; 17: 698.
96. Paramsothy M, Khanijow V, Ong TO. Use of gallium-67 in the assessment of response to antibiotic therapy in malignant otitis externa-a case report. Singapore Med J 1997; 38: 347-9. (Pubitemid 27382506)
97. Okpala NC, Siraj QH, Nilssen E, Pringle M. Radiological and radionuclide investigation of malignant otitis externa. J Laryngol Otol 2005; 119: 71-5.
98. Redleaf MI, Angeli SI, McCabe BF. Indium-111-labeled white blood cell scintigraphy as an unreliable indicator of malignant external otitis resolution. Ann Otol Rhinol Laryngol 1994; 103: 444-8.
99. Hardoff R, Gips S, Uri N et al. Semiquantitative skull planar and SPET bone scintigraphy in diabetic patients: differentiation of necrotizing (malignant) external otitis from severe external otitis. J Nucl Med 1994; 35: 411-5. (Pubitemid 24079965)
100. Stokkel MP, Boot CN, van Eck-Smit BL. SPET gallium scintigraphy in malignant external otitis: initial staging and follow-up. Case reports. Laryngoscope 1996; 106: 338-40.
101. Stokkel MP, Takes RP, van Eck-Smit BL, Baatenburg de Jong RJ. The value of quantitative gallium-67 single-photon emission tomography in the clinical management of malignant external otitis. Eur J Nucl Med 1997; 24: 1429-32.
102. Zwas ST, Czerniak P. Head and brain scan findings in rhinocerebral mucormycosis: case report. J Nucl Med 1975; 16: 925-7.
103. Mnif N, Hmaied E, Oueslati S et al. Imaging of rhinocerebral mucormycosis. J Radiol 2005; 86: 1017-20.
104. Boubaker A, Prior JO, Meuwly JY, Bischof-Delaloye A. Radionuclide investigations of the urinary tract in the era of multimodality imaging. J Nucl Med 2006; 47: 1819-36.
105. He W, Fischman AJ. Nuclear imaging in the genitourinary tract: recent advances and future directions. Radiol Clin North Am 2008; 46: 25-43. (Pubitemid 351323819)
106. Rossleigh MA. Scintigraphic imaging in renal infections. Q J Nucl Med Mol Imaging 2009; 53: 72-7.
107. Grbac-Ivanković S, Smokvina A, Girotto N, Licul V. Initial presentation of scintigraphic changes during the first episode of acute pyelonephritis in children: simultaneous evaluation with MAG3 and DMSA. Nuklearmedizin 2007; 46: 129-34.
108. Hardy RD, Austin JC. DMSA renal scans and the top-down approach to urinary tract infection. Pediatr Infect Dis J 2008; 27: 476-7.
109. Faust WC, Diaz M, Pohl HG. Incidence of post-pyelonephritic renal scarring: a meta-analysis of the dimercaptosuccinic acid literature. J Urol 2009; 181: 290-7.
110. Hamoui N, Hagerty JA, Maizels M et al. Ultrasound fails to delineate significant renal pathology in children with urinary tract infections: a case for dimercapto-succinic acid scintigraphy. J Urol 2008; 180: 1639-42.
111. 99mTc dimercaptosuccinic acid. Nucl Med Commun 2004; 25: 967-70.
112. 18F- fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease. Am J Kidney Dis 2003; 41: E18-E21.
113. Gilbert BR, Cerqueira MD, Eary JF et al. Indium-111 white blood cell scan for infectious complications of polycystic renal disease. J Nucl Med 1985; 26: 1283-6.
114. Bretan PN Jr, Price DC, McClure RD. Localization of abscess in adult polycystic kidney by indium-111 leukocyte scan. Urology 1988; 32: 169-71.
115. Chandeysson PL, Varma VM. Renal scan in papillary necrosis. Clin Nucl Med 1982; 7: 294.
116. Blaivas M, Adhikari S. Diagnostic utility of cholescintigraphy in emergency department patients with suspected acute cholecystitis: comparison with bedside RUQ ultrasonography. J Emerg Med 2007; 33: 47-52. (Pubitemid 47042323)
117. Kalimi R, Gecelter GR, Caplin D et al. Diagnosis of acute cholecystitis: sensitivity of sonography, cholescintigraphy, and combined sonography- cholescintigraphy. J Am Coll Surg 2001; 193: 609-13. 122.
118. 99mTc-IDA cholescintigraphic patterns in acute cholecystitis. Radiology 1981; 138: 167-75. (Pubitemid 11210486)
119. Ziessman HA. Acute cholocystitis, biliary obstruction, and biliary leakage. Semin Nucl Med 2003; 33: 279-96.
120. Kistler AM, Ziessman HA, Gooch D, Bitterman P. Morphine-augmented cholescintigraphy in acute cholecystitis. A satisfactory alternative to delayed imaging. Clin Nucl Med 1991; 16: 404-6.
121. Fig LM, Wahl RI, Stewart RE et al. Morphine-augmented cholescintigraphy: Its efficacy in detection of acute cholecystitis. J Nucl Med 1991; 323: 1231-3